Home » Authors » Rachelle H.B. Fishman

Articles by Rachelle H.B. Fishman

Teva Establishing Biotech Fund As Growth Continues In Israel

Feb. 21, 2001

By Rachelle H.B. Fishman

Monitor Report Advises Israel To Take Initiatives In Biotech

Feb. 7, 2001

By Rachelle H.B. Fishman

IDgene Raises $7.6M Privately For Genetic Variability Program

Jan. 31, 2001

By Rachelle H.B. Fishman

New Biotechnology Center Adds Options For Israeli Start-Up Firms

Jan. 3, 2001

By Rachelle H.B. Fishman

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...